Last news
China's Yangtze River Pharmaceutical Group Expands Global Footprint as Quality Drives Growth

China's Yangtze River Pharmaceutical Group Expands Global Footprint as Quality Drives Growth

TAIZHOU, China, April 29, 2026 /PRNewswire/ -- In 2025, Yangtze River Pharmaceutical Group (YRPG) made significant progress in both global growth and quality initiatives. The company's international revenue increased more than fourfold year over...

STARTRADER Transforms Basketball Court for 10,000 Youth Annually in Vietnam

STARTRADER Transforms Basketball Court for 10,000 Youth Annually in Vietnam

STARTRADER Completes Basketball Court Upgrade Serving 10,000 Youth Annually The newly upgraded basketball court is now in active use, providing a safe, structured sports environment for daily learning and development. HO CHI MINH CITY, Vietnam,...

GAC Debuts Three Global Models at Auto China 2026 as It Accelerates Global Push

GAC Debuts Three Global Models at Auto China 2026 as It Accelerates Global Push

BEIJING, April 29, 2026 /PRNewswire/ -- On April 24, at the Auto China 2026, GAC International held its first dedicated global launch event, unveiling an upgraded global strategy system. The event drew a larger audience than ever before, with...

JinkoSolar Files 2025 Annual Report on Form 20-F

JinkoSolar Files 2025 Annual Report on Form 20-F

SHANGRAO, China, April 29, 2026 /PRNewswire/ -- JinkoSolar Holding Co., Ltd. ("JinkoSolar" or the "Company") (NYSE: JKS), a global leader in clean energy technology, today announced that the Company filed its annual report on Form 20-F for the...

European Commission (EC) Approves Henlius and Organon's POHERDY® (pertuzumab), the First Approved Biosimilar to PERJETA (pertuzumab) in Europe

European Commission (EC) Approves Henlius and Organon's POHERDY® (pertuzumab), the First Approved Biosimilar to PERJETA (pertuzumab) in Europe

SHANGHAI, April 29, 2026 /PRNewswire/ -- Shanghai Henlius Biotech, Inc. (2696.HK), and Organon (NYSE: OGN) today announced the European Commission (EC) has granted marketing authorization for POHERDY® (pertuzumab) 420 mg/14 mL injection for...

Cognizant to Acquire Astreya, Deepening Its AI-First Managed Services Capabilities at Scale

Cognizant to Acquire Astreya, Deepening Its AI-First Managed Services Capabilities at Scale

Acquisition will expand Cognizant's AI builder technology stack with production-grade AI operations capabilities Astreya, a specialist in AI infrastructure and data center services with deep expertise in data center and managed workplace services,...

Appier Advances AI Self-Awareness to Unlock Enterprise ROI

Appier Advances AI Self-Awareness to Unlock Enterprise ROI

Four research capabilities position Agentic AI as a trustworthy decision partner for enterprises SINGAPORE, April 29, 2026 /PRNewswire/ -- As AI systems become more capable of answering questions and executing tasks, the central question for...

Bybit Launches "Master Trader's Showtime: TradFi vs Crypto" Tournament With 200,000 USDT Prize Pool

Bybit Launches "Master Trader's Showtime: TradFi vs Crypto" Tournament With 200,000 USDT Prize Pool

DUBAI, UAE, April 29, 2026 /PRNewswire/ -- Bybit, the world's second-largest cryptocurrency exchange by trading volume, has announced the launch of its "Master Trader's Showtime: TradFi vs Crypto," a multi-round global trading competition designed...

1 ... 4 5 6 7 8 9 10 11 12 ... 4370
menu
menu